Search

Your search keyword '"Ruzyllo, W."' showing total 400 results

Search Constraints

Start Over You searched for: Author "Ruzyllo, W." Remove constraint Author: "Ruzyllo, W."
400 results on '"Ruzyllo, W."'

Search Results

2. Factors associated with early catheterization in patients randomized to the conservative strategy in the ISCHEMIA Trial

4. Initial Invasive or Conservative Strategy for Stable Coronary Disease

6. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

15. Ezetimibe added to statin therapy after acute coronary syndromes

16. Edoxaban versus warfarin in patients with atrial fibrillation

17. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

18. Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme

20. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

21. Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48

22. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

23. P5866Economic outcomes of the CAT-CAD randomised trial assessing coronary artery computed tomography as the first-choice anatomic test for individuals with suspected significant coronary artery disease

24. The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina

25. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the Trimpol II study

26. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48

27. The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation

28. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization

29. Guidelines for percutaneous coronary interventions

31. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

32. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

33. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart

34. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

35. Response to letter regarding article, 'efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation'

36. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

38. Management of acute myocardial infarction in patients presenting with ST-elevation

39. NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter doubleblind randomized study

40. Лечение острого инфаркта миокарда с подъемом сегмента ST. Рабочая группа Европейского общества кардиологов по острому инфаркту миокарда с подъемом сегмента ST

42. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

43. Management of Acute myocardial infarction in patients presenting with segment elevation. The Task Force on the Management of Acute Myocardial Infarction of theEuropean Society of Cardiology

45. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology

47. Edoxaban versus warfarin in patients with atrial fibrillation

48. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for Stroke prevention in atrial fibrillation

49. Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)

Catalog

Books, media, physical & digital resources